BTK-IN-20
BTK-IN-20 (compound 283) is a BTK tyrosine kinase inhibitor and a 1H-pyrazolo[3,4-d]pyrimidine derivative. BTK-IN-20 can be used for the research of cancer and inflammation[1].
Product Specifications
CAS Number
[1581714-50-2]
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/btk-in-20.html
Solubility
10 mM in DMSO
Smiles
NC1=C(C(C2=CC=C(OC3=CC=CC=C3)C=C2F)=NN4[C@H]5CN(C(/C(C#N)=C\C(C)(C)C)=O)CCC5)C4=NC=N1
Molecular Formula
C30H30FN7O2
Molecular Weight
539.60
References & Citations
[1]Goldstein, David Michael. Preparation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as tyrosine kinase inhibitors. US8673925. 2014.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
043970-ML750 100 µL
YTHD3, ID (YTHDF3, YTH domain family protein 3) (MaxLight 750) discontinued
Ask
View Details 
